EFFICACY OUTCOMES OF PLACEBO MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RESPONDED TO PLACEBO INDUCTION THERAPY: RESULTS FROM THE PHASE 3 COMMAND STUDY

被引：0
|
作者：
Atreya, Raja
Ferrante, Marc
Afzali, Anita
Bamias, Giorgos
Long, Millie D.
Neimark, Ezequiel
Levine, Phillip
Cheng, Ling
Kalabic, Jasmina
Hecht, Patrick
Vladea, Ramona C.
Schreiber, Stefan
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1792
引用
收藏
页码：S815 / S816
页数：2
相关论文
共 50 条
  • [41] PK, EFFICACY AND SAFETY OF MIRIKIZUMAB AS INDUCTION THERAPY IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 SHINE-1 STUDY
    Kaplan, Jess
    Bousvaros, Athos
    Turner, Dan
    Dubinsky, Marla C.
    Komocsar, Wendy
    Larkin, Amy E.
    Johns, Jordan
    Zhang, Xin
    Little, Cheryl A.
    Crandall, Wallace
    Arora, Vipin
    Hyams, Jeffrey S.
    GASTROENTEROLOGY, 2023, 164 (06) : S169 - S169
  • [42] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Panes, J.
    Rubin, D. T.
    Vermeire, S.
    Lindsay, J. O.
    Sands, B. E.
    Su, C.
    Friedman, G.
    Zhang, H.
    Kayhan, C.
    Manuchehri, A.
    Healey, P.
    GUT, 2017, 66 : A121 - A122
  • [43] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Panes, Julian
    Rubin, David T.
    Vermeire, Severine
    Lindsay, James O.
    Sands, Bruce E.
    Su, Chinyu
    Friedman, Gary
    Zhang, Haiying
    Kayhan, Cem
    Manuchehri, Alireza
    Healey, Paul J.
    GASTROENTEROLOGY, 2017, 152 (05) : S601 - S602
  • [44] Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis
    Panes, J.
    Rubin, D. T.
    Vermeire, S.
    Lindsay, J. O.
    Sands, B. E.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S315 - S317
  • [45] Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
    Danese, Silvio
    Vermeire, Severine
    Zhou, Wen
    Pangan, Aileen L.
    Siffledeen, Jesse
    Greenbloom, Susan
    Hebuterne, Xavier
    D'Haens, Geert
    Nakase, Hiroshi
    Panes, Julian
    Higgins, Peter D. R.
    Juillerat, Pascal
    Lindsay, James O.
    Loftus, Edward V., Jr.
    Sandborn, William J.
    Reinisch, Walter
    Chen, Min-Hu
    Gonzalez, Yuri Sanchez
    Huang, Bidan
    Xie, Wangang
    Liu, John
    Weinreich, Michael A.
    Panaccione, Remo
    LANCET, 2022, 399 (10341): : 2113 - 2128
  • [46] A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC
    Sandborn, W. J.
    Feagan, B. G.
    Marano, C. W.
    Strauss, R.
    Johanns, J.
    Zhang, H.
    Colombel, J.
    Reinisch, W.
    Gibson, P.
    Collins, J.
    Jarnerot, G. A.
    Rutgeerts, P. J.
    GASTROENTEROLOGY, 2012, 142 (05) : S161 - S161
  • [47] A phase 2 study investigating the efficacy and safety of dupilumab versus placebo in adults with moderately to severely active ulcerative colitis with an eosinophilic phenotype
    Gottlieb, E.
    Binion, D.
    Feagan, B.
    Laws, E.
    Nivens, C.
    Maloney, J.
    Abdulai, R.
    Radin, A.
    Glotfelty, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1354 - I1355
  • [48] Impact of Guselkumab Therapy on Histologic and Combined Histologic and Endoscopic Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Week 12 Results From the Phase 3 QUASAR Induction Study
    Panes, Julian
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Yarandi, Shadi
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Sridhar, Sunandini
    Branigan, Patrick
    Miao, Ye
    Zhang, Hongyan
    Hebuterne, Xavier
    Gyokeres, Tibor
    Hirai, Fumihito
    Hisamatsu, Tadakazu
    Rubin, David T.
    Feagan, Brian G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S874 - S875
  • [49] Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
    Loftus, Edward V.
    Takeuchi, Ken
    Gao, Xiang
    Panaccione, Remo
    Danese, Silvio
    Ilo, Dapo
    Finney-Hayward, Tricia
    Phillips, Charles
    Yao, Xuan
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S359 - S359
  • [50] Cumulative Response to Guselkumab Through Week 24 of Induction in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study
    Rubin, David T.
    Sands, Bruce E.
    Lichtenstein, Gary R.
    Baker, Thomas
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Miao, Ye
    Zhang, Hongyan
    Nancey, Stephane
    Allegretti, Jessica R.
    Feagan, Brian G.
    Hisamatsu, Tadakazu
    Panes, Julian
    Dignass, Axel
    Bressler, Brian
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S672 - S673
12345